Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
responsible. In this PhD, you will design and synthesise novel heterogeneous catalysts, including supported metal nanoparticles, mixed metal oxides, and microporous materials, for the selective oxidation
-
editing platforms delivered by AAV vectors and lipid nanoparticles to treat Ornithine Transcarbamylase (OTC) deficiency in utero. This is an exciting opportunity to contribute to a field on the cusp
-
purification and characterization techniques for small molecules and macromolecules. Experience with nanoparticle uptake and efficacy studies in cells, and/or in vivo models is a plus. Preferred Qualifications
-
nanoparticles for applications in nanomedicine, animal-derived food safety, and human health risk assessment; (2) collection and meta-analysis of pharmacokinetic and tissue distribution data of nanoparticles in
-
previous experience in microbiology, cell biology, nanoparticle synthesis, particularly liposomes. 7. Recruitment method: In accordance with articles 26 of the Regulation of Research, Science and Technology
-
nanotechnology, material science, nano and quantum technologies. We look for candidates interested in in further developing NIST unique PTIR instrumentation (see description at: https://www.nist.gov/programs
-
can provide new functionalities. Examples of such materials include 2D semiconductor and magnetic materials, light- and field-tunable materials, low loss amorphous/nanoparticle composites, MRI contrast
-
and chemistry of nanoparticles. Nuclear physics concentrates on nuclear astrophysics, nuclear structure and applied accelerator-based research, and particle physics on the physics of the strong
-
available in the Department of Radiation Oncology at the University of Iowa. The successful candidate will participate in research projects focused on creation of delivery of mRNA nanoparticles. The ideal
-
-academic careers. https://www.yorkshirebiosciencedtp.ac.uk Project Description: RNA medicines, spanning both vaccines and therapeutics, are revolutionising healthcare, but major bottlenecks in production and